Perspectiva histórica del trastorno del espectro del autismo / Historical perspective of autism spectrum disorder

RESUMEN INTRODUCCIÓN: El presente artículo incluye una mirada histórica de algunas teorías y clasificaciones del trastorno del espectro del autismo (TEA), incluyendo a los autores más reconocidos y las perspectivas semiológicas vigentes. Se pretende contribuir así a la unificación de criterios entre los profesionales, y propender por la reflexión acerca de las consecuencias de una conceptualización desacertada del trastorno. MATERIALES Y MÉTODO: Se trata de una revisión documental de artículos indexados en bases de datos, y otros documentos seleccionados intencionalmente. RESULTADOS: Tres categorías a saber fueron consideradas para la organización de la información: a) de la ficción a la ciencia: el paso de la sintomatología mítica a la clasificación nosológica; b) los pioneros austríacos: la dualidad inicial que se transformó en espectro; y c) trastorno del espectro del autismo: una trayectoria en la estructuración de sus criterios diagnósticos. DISCUSIÓN Y CONCLUSIONES: La variabilidad en las hipótesis etiológicas, así como en la manifestación de los síntomas nucleares del TEA, han impactado en su clasificación y abordaje terapéutico. Se requiere una actualización permanente de los profesionales por el avance de la genética y las neurociencias, siendo posible la futura generación de cambios en el rol de los profesionales que intervienen en su detección, evaluación e intervención.

ABSTRACT Introduction: This article involves a historical review of some theories and classifications of autism spectrum disorder (ASD), including the most recognized authors and current semiological perspectives. In this way, it is intended to contribute to the unification of criteria among professionals, and to encourage reflection on the consequences of an unwise conceptualization of the disorder. Materials and methods: It is a documentary review of articles indexed in databases, and other intentionally selected documents. Results: Three categories, namely, were considered for the organization of the information: a) from fiction to science: the transition from mythical symptomatology to nosological classification; b) the Austrian pioneers: the initial duality that became a spectrum; and c) autism spectrum disorder: a trajectory in the structuring of its diagnostic criteria. Discussion and conclusions: The variability in the etiological hypotheses, as well as in the manifestation of the core symptoms of ASD, have impacted its classification and therapeutic approach. A permanent update of professionals is required due to the advancement of genetics and neurosciences, making possible the future generation of changes in the role of professionals involved in its detection, evaluation and intervention.

18F-FDG PET/CT in ovarian cancer recurrence: Clinical impact, correlation with ceCT and CA-125, and prognostic value.

AIM: To evaluate 18F-FDG-PET/CT for suspected ovarian cancer relapse with negative/inconclusive conventional imaging, or restaging potentially resectable ovarian cancer relapse. MATERIAL AND METHODS: Thirty-six cases and 140 locations were studied. PET/CT, ceCT and serum CA-125 was conducted in all cases. Nineteen cases were requested for restaging, 17 for suspected relapse. We compared ceCT and PET/CT, assessed by histopathology or radiological follow-up, calculating sensitivity (S) and positive predictive value (PPV) by cases and lesions. We evaluated the correlation between size, number, uptake of the lesions and CA-125. We conducted survival analysis, using ROC curves to calculate the optimal cut-off of SUVmax for survival prediction. We checked whether PET/CT modify the therapeutic attitude vs. conventional imaging. RESULTS: PET/CT and ceCT were concordant in 12 cases: 11 positives (30 lesions), all confirmed. There was 1 FN. In the 24 non-concordant, PET/CT was positive in 19 (97 lesions); ceCT in 21 (59 lesions); 54% of the lesions were concordant. Overall, PET/CT detected 127 lesions, with S=97% and PPV=100%. ceCT detected 89 lesions, with S=61% and PPV=90%. No significant correlation was found between CA-125 and the other parameters. PET/CT detected 10 positive cases, with normal CA-125. PET/CT modified therapeutic management in 15 cases. Significant differences were found in survival with SUVmax=11.8 CONCLUSIONS: PET/CT plays an important role in ovarian cancer relapse, with sensitivity and PPV higher than ceCT, modified therapeutic management in up to 42% of cases, and could be a valuable tool for predicting survival.

Biological Features and Prognostic Impact of Bone Marrow Infiltration in Patients with Diffuse Large B-Cell Lymphoma.

The biology and clinical impact of bone marrow (BM) infiltration in patients with diffuse large B-cell lymphoma (DLBCL) remains unclear in the rituximab era. We retrospectively analyzed 232 patients diagnosed with DLBCL at our center between 1999 and 2014. Concordant-presence of large cells similar to those of the lymph node biopsy- and discordant-infiltration by small cells forming lymphoid aggregates, lacking cytological atypia-BM infiltration was defined by histological criteria and further characterized by flow cytometry (FCM). Cell of origin (COO) was determined using Hans' algorithm. For the clonal relationship between tumor and discordant BM, the VDJH rearrangement was analyzed. Survival analyses were restricted to 189 patients treated with rituximab and chemotherapy. Thirty-six (16%) had concordant, and 37 (16%) discordant BM infiltration. FCM described different indolent lymphomas among discordant cases, clonally related with DLBCL in 10/13 available samples. Median follow-up was 58 months. 5-year-progression-free survival (PFS) for non-infiltrated, discordant and concordant groups was 68%, 65% and 30%, respectively (p < 0.001). Combining COO and BM infiltration, patients with discordant BM and non-germinal center B-cell COO also had decreased 5-year-PFS (41.9%). In multivariate analysis, concordant BM had an independent effect on PFS (HR 2.5, p = 0.01). Five-year cumulative incidence of central nervous system (CNS) relapse was 21%, 4% and 1% in concordant, discordant and non-infiltrated groups, respectively (p < 0.001). In conclusion, concordant BM infiltration represents a subset with poor prognosis, whereas the prognostic impact of discordant BM infiltration could be limited to non-CGB cases.

Assessing the impact of educational intervention in patients with hypertension.

BACKGROUND: It is accepted that patient education can be beneficial in the treatment of chronic diseases. We conducted an educational intervention (EI) in hypertensive patients seen at Primary Care centres (PCC) and specialised Hypertension Units (SHU). OBJECTIVES: To assess patient's knowledge of hypertension and to verify the impact of this educational initiative. METHODS: A multicentre quasi-experimental study with the participation of 120 patients with hypertension. EI consisted of oral and written information which included the definition of hypertension, causes, cardiovascular risk factors and means of control. A self-administered questionnaire was used to assess patient's knowledge before and after EI. RESULTS: Sixty-two (52%) patients were from PCC and 58 (48%) from SHU (mean age: 61 ± 13.3 years, 59% were women). There were no differences in baseline characteristics between patients attending at PCC and SHU. The definition of hypertension (blood pressure ≥140 mmHg and/or ≥90 mmHg was known by 48% and 99% of the participants before and after EI, respectively (p < 0.001). Poor baseline knowledge about the risks of hypertension was related to kidneys (54%) and eyes (58%). After EI this knowledge increased to 100% (p < 0.001 and p < 0.001, respectively). A significant improvement in knowledge about medication was observed (51% before and 87% after EI; p = 0.004). CONCLUSIONS: This study shows a positive impact of EI to improve patients' knowledge about hypertension. However, further studies are needed to assess if EI produces behaviour changes in the long term, as this might enhance optimal blood pressure control to prevent kidney disease or delay its progression.